Eupraxia Pharmaceuticals Inc. (EPRX)
Market Open
3 Mar, 16:20
NASDAQ (CM) NASDAQ (CM) Primary 
TSX $
8. 15
-0.15
-1.81%
$
273.87M Market Cap
- P/E Ratio
- Div Yield
31,297 Volume
- Eps
$ 8.3
Previous Close Day Range
8.07 8.21
Year Range
2.68 9.32
Want to track EPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
EPRX earnings report is expected in 16 days (19 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
EPRX Earnings Reports FAQ
What is the earnings per share (EPS) for EPRX?
EPS data for EPRX is currently not available, as Eupraxia Pharmaceuticals Inc has not reported recent earnings.
What is the company's earnings growth rate?
Eupraxia Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-19, based on the EPRX's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Eupraxia Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for EPRX at this time, as Eupraxia Pharmaceuticals Inc has no recent EPS data to calculate it.
